Therapeutic Antibody Against Phosphorylcholine Preserves Coronary Function and Attenuates Vascular

Autor: Mia, Ståhle, Johanna M U, Silvola, Sanna, Hellberg, Margreet, de Vries, Paul H A, Quax, Jeffrey, Kroon, Petteri, Rinne, Alwin, de Jong, Heidi, Liljenbäck, Nina, Savisto, Anna, Wickman, Erik S G, Stroes, Seppo, Ylä-Herttuala, Pekka, Saukko, Tommy, Abrahamsson, Knut, Pettersson, Juhani, Knuuti, Anne, Roivainen, Antti, Saraste
Rok vydání: 2019
Předmět:
Zdroj: JACC: Basic to Translational Science
ISSN: 2452-302X
Popis: Visual Abstract
Highlights • Phosphorylcholine is a pro-inflammatory epitope in atherogenic oxidized phospholipids. • This study investigated effects of a novel monoclonal IgG1 antibody against PC on vascular function and atherosclerotic inflammation. • Treatment with phosphorylcholine antibody preserved coronary flow reserve and decreased uptake of 18F-FDG in atherosclerotic lesions in hypercholesterolemic mice. • Noninvasive imaging techniques represent translational tools to assess the efficacy of phosphorylcholine-targeted therapy on coronary artery function and atherosclerosis.
Summary This study showed that treatment with a therapeutic monoclonal immunoglobulin-G1 antibody against phosphorylcholine on oxidized phospholipids preserves coronary flow reserve and attenuates atherosclerotic inflammation as determined by the uptake of 18F-fluorodeoxyglucose in atherosclerotic mice. The noninvasive imaging techniques represent translational tools to assess the efficacy of phosphorylcholine-targeted therapy on coronary artery function and atherosclerosis in clinical studies.
Databáze: OpenAIRE